141 related articles for article (PubMed ID: 16574955)
1. Identification of the nonreceptor tyrosine kinase MATK/CHK as an essential regulator of immune cells using Matk/CHK-deficient mice.
Lee BC; Avraham S; Imamoto A; Avraham HK
Blood; 2006 Aug; 108(3):904-7. PubMed ID: 16574955
[TBL] [Abstract][Full Text] [Related]
2. Analysis of CSK homologous kinase (CHK/HYL) in hematopoiesis by utilizing gene knockout mice.
Hamaguchi I; Yamaguchi N; Suda J; Iwama A; Hirao A; Hashiyama M; Aizawa S; Suda T
Biochem Biophys Res Commun; 1996 Jul; 224(1):172-9. PubMed ID: 8694808
[TBL] [Abstract][Full Text] [Related]
3. The Csk-like proteins Lsk, Hyl, and Matk represent the same Csk homologous kinase (Chk) and are regulated by stem cell factor in the megakaryoblastic cell line MO7e.
Grgurevich S; Linnekin D; Musso T; Zhang X; Modi W; Varesio L; Ruscetti FW; Ortaldo JR; McVicar DW
Growth Factors; 1997; 14(2-3):103-15. PubMed ID: 9255603
[TBL] [Abstract][Full Text] [Related]
4. Association of csk-homologous kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in breast cancer cells.
Zrihan-Licht S; Lim J; Keydar I; Sliwkowski MX; Groopman JE; Avraham H
J Biol Chem; 1997 Jan; 272(3):1856-63. PubMed ID: 8999872
[TBL] [Abstract][Full Text] [Related]
5. Complex regulation of the Csk homologous kinase (Chk) by IL-4 family cytokines and IFN-gamma in human peripheral blood monocytes.
Hiremath MM; Mikhael AI; Taylor LS; Musso T; McVicar DW
Mol Immunol; 2004 Jul; 41(9):901-10. PubMed ID: 15261462
[TBL] [Abstract][Full Text] [Related]
6. Mice lacking a functional chk gene have no apparent defects in the hematopoietic system.
Samokhvalov I; Hendrikx J; Visser J; Belyavsky A; Sotiropolous D; Gu H
Biochem Mol Biol Int; 1997 Sep; 43(1):115-22. PubMed ID: 9315289
[TBL] [Abstract][Full Text] [Related]
7. Chk, a Csk family tyrosine protein kinase, exhibits Csk-like activity in fibroblasts, but not in an antigen-specific T-cell line.
Davidson D; Chow LM; Veillette A
J Biol Chem; 1997 Jan; 272(2):1355-62. PubMed ID: 8995444
[TBL] [Abstract][Full Text] [Related]
8. Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice.
Nagy Z; Mori J; Ivanova VS; Mazharian A; Senis YA
Blood; 2020 Apr; 135(18):1574-1587. PubMed ID: 32016283
[TBL] [Abstract][Full Text] [Related]
9. CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylation.
Chüeh AC; Advani G; Foroutan M; Smith J; Ng N; Nandurkar H; Lio DS; Zhu HJ; Chong YP; Verkade H; Fujita DJ; Bjorge J; Basheer F; Lim JP; Luk I; Dhillon A; Sakthianandeswaren A; Mouradov D; Sieber O; Hollande F; Mariadason JM; Cheng HC
Oncogene; 2021 Apr; 40(17):3015-3029. PubMed ID: 33767439
[TBL] [Abstract][Full Text] [Related]
10. Csk homologous kinase (CHK), unlike Csk, enhances MAPK activation via Ras-mediated signaling in a Src-independent manner.
Zagozdzon R; Kaminski R; Fu Y; Fu W; Bougeret C; Avraham HK
Cell Signal; 2006 Jun; 18(6):871-81. PubMed ID: 16168623
[TBL] [Abstract][Full Text] [Related]
11. Translocation of the Csk homologous kinase (Chk/Hyl) controls activity of CD36-anchored Lyn tyrosine kinase in thrombin-stimulated platelets.
Hirao A; Hamaguchi I; Suda T; Yamaguchi N
EMBO J; 1997 May; 16(9):2342-51. PubMed ID: 9171348
[TBL] [Abstract][Full Text] [Related]
12. The Csk homologous kinase, Chk, binds tyrosine phosphorylated paxillin in human blastic T cells.
Grgurevich S; Mikhael A; McVicar DW
Biochem Biophys Res Commun; 1999 Mar; 256(3):668-75. PubMed ID: 10080957
[TBL] [Abstract][Full Text] [Related]
13. MMP-2 regulates Src activation via repression of the CHK/MATK tumor suppressor in osteosarcoma.
Maybee DV; Cromwell CR; Hubbard BP; Ali MAM
Cancer Rep (Hoboken); 2023 Dec; 7(2):e1946. PubMed ID: 38064181
[TBL] [Abstract][Full Text] [Related]
14. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
[TBL] [Abstract][Full Text] [Related]
15. CHK down-regulates SCF/KL-activated Lyn kinase activity in Mo7e megakaryocytic cells.
Price DJ; Rivnay B; Avraham H
Biochem Biophys Res Commun; 1999 Jun; 259(3):611-6. PubMed ID: 10364466
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the Csk homologous kinase facilitates phosphorylation of Akt/PKB in MCF-7 cells.
Zagozdzon R; Bougeret C; Fu Y; Avraham HK
Int J Oncol; 2002 Dec; 21(6):1347-52. PubMed ID: 12429987
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of Csk homologous kinase (CHK) in normal brain and brain tumors.
Kim SO; Avraham S; Jiang S; Zagozdzon R; Fu Y; Avraham HK
Cancer; 2004 Sep; 101(5):1018-27. PubMed ID: 15329911
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the Csk homologous kinase (Chk tyrosine kinase) induces multinucleation: a possible role for chromosome-associated Chk in chromosome dynamics.
Yamaguchi N; Nakayama Y; Urakami T; Suzuki S; Nakamura T; Suda T; Oku N
J Cell Sci; 2001 May; 114(Pt 9):1631-41. PubMed ID: 11309195
[TBL] [Abstract][Full Text] [Related]
19. Expression, purification, and biochemical characterization of Chk, a soluble protein tyrosine kinase.
Ayrapetov MK; Lee S; Sun G
Protein Expr Purif; 2003 Jun; 29(2):148-55. PubMed ID: 12767803
[TBL] [Abstract][Full Text] [Related]
20. Csk homologous kinase (CHK) and ErbB-2 interactions are directly coupled with CHK negative growth regulatory function in breast cancer.
Kim S; Zagozdzon R; Meisler A; Baleja JD; Fu Y; Avraham S; Avraham H
J Biol Chem; 2002 Sep; 277(39):36465-70. PubMed ID: 12122014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
